A clinical study of the V540A vaccine in healthy adults (V540A-001)
Latest Information Update: 15 Sep 2025
At a glance
- Drugs V 540 A (Primary)
- Indications Human papillomavirus infections
- Focus Adverse reactions; First in man
- Sponsors Merck Sharp & Dohme
Most Recent Events
- 15 Sep 2025 New trial record